Competition and Patent Law in the Pharmaceutical Sector: An International Perspective (International Competition Law, 65) - Image 1

£219.00

Wolters Kluwer Competition and Patent Law in the Pharmaceutical Sector: An International Perspective (International Competition Law, 65)

Name: Competition and Patent Law in the Pharmaceutical Sector: An International Perspective (International Competition Law, 65)
Brand: Wolters Kluwer
Price: 219.0 GBP
Availability: InStock

International

It has never been this cheap. We have no record of a lower price.

£219 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 46 days • 46 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 46 days • 1 price levels

Days at Price

Price Analysis

Most common price: £219 (46 days, 100.0%)

Price range: £219 - £219

Price levels: 1 different prices over 46 days

Description

The apparent contradiction between intellectual property (IP) rights (particularly patents) and competition is often noted: in ostensibly aiming to promote innovation and long-term competition, the patent system in fact provides a temporary right to exclude. Is it possible to adjust patent policies to better account for the trade-off between static and dynamic welfare, and minimize the risks of anticompetitive behaviour implemented through the misuse of patents? With a focus on the pharmaceutical sector, this book, the first to deal with this issue on a global basis, tackles the clashes of case law by Courts and antitrust enforcement by competition authorities that undermine the predictability of solutions to this problem and increase the risk of fundamental rights violations and excessive transitional costs for enterprises. Examining the approaches to both competition and IP regulation in fourteen leading jurisdictions, the analysis provides a comparative perspective on recent relevant regulations and case law in the pharmaceutical sector. Thirty-one contributions by internationally known experts in both fields judges in specialized courts, chairmen and board members of national competition authorities, and well known scholars and practitioners focus on the salient topics and on the interplay between patent law and competition law, with an insight into the human rights issues that arise. Among the topics covered are the following: - balancing the human right to health with competition law and IP law; - patent lifecycle strategies; - reverse payment settlements; - abusive litigation; - damages for patents and antitrust infringements; - co-marketing and co-promotion agreements; and - the role of the Unified Patent Court. The jurisdictions covered are Brazil, Canada, China, France, Germany, Greece, India, Italy, Japan, the Netherlands, Russia, South Africa, the United Kingdom, and the United States. The books ultimate and challenging proposal identifies the pharmaceutical sector itself as a starting point for reshaping a more procompetitive and harmonized system of regulation. In its dedication to striking the right balance between static (short-term) and dynamic (long-term) efficiency, and thus opening the way to a more balanced approach and a higher standard of harmonization in the pharmaceutical sector, this book has no peers. As a detailed comparative analysis and clarification of current trends worldwide in regulation and jurisprudence at the crossroads between IP and competition law, it suggests new ground for steps forward in an essential area for modern economies. It will be of great value to lawyers, economists, and policymakers in both fields of IP and competition law. About the Author Gabriella Muscolo Commissioner at the Italian Competition Authority, former Judge at the specialized section for IP and Competition Law Litigation of the Court of Rome, former member of the Enlarged Board of Appeal of the European Patent Office, author of several publication in the field of IP Law, Competition Law and Company Law and usual lecturer in several Universities in Italy and abroad. Giovanni Pitruzzella Chairman of the Italian Competition Authority full professor of Constitutional Law University of Palermo former lawyer at the bar of Palermo, author of several publications in the field of European Constitutional Law and Competition Law.

Product Specifications

Brand: Wolters Kluwer
Format: hardcover
ASIN: 9041159274
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 15 June 2016
Listed Since: 27 May 2016

Barcode

No barcode data available

Wolters Kluwer Competition and Patent Law in the Pharmaceutical Sector: An International Perspective (International Competition Law, 65)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Research Handbook on International Competition Law

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Antitrust in Pharmaceutical Markets & Geographical Rules of Origin (LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition)

Pharmaceutical Antitrust: An Analysis of US and EU Law

Intellectual Property and Antitrust: A Comparative Economic Analysis of US and EU Law (New Horizons in Competition Law and Economics series)

EU Competition Law and Intellectual Property Rights (Elgar Competition Law and Practice series)

EU Competition Law and Intellectual Property Rights: The Regulation of Innovation

Abusive Practices in Competition Law - Edward Elgar Publishing

European SPCs Unravelled: A Practitioner’s Guide to Supplementary Protection Certificates in Europe

Competition Policy: An Empirical and Economic Approach

EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)

Competition Law of the European Union

Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Routledge Research in Intellectual Property)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Antitrust Settlements: How a Simple Agreement Can Drive the Economy (International Competition Law, 80)

European Policies on Competition, Trade and Industry: Conflict and Complementarities

Eu Competition Law: Between Public and Private Enforcement ( International Competition Law Series 55)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Springer - Intellectual Property Rights in Pharmaceutical Test Data

Contract Manufacturing of Medicines

IAN S. FORRESTER QC LL.D. A Scot without Borders Liber Amicorum - Volume II

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)